Igene Biotechnology, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IGNE research report →
Companywww.igene.com
Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company supplies natural astaxanthin, a nutrient used as a source of pigment for coloring farmed salmon and trout species.
- CEO
- Joseph L. Downs
- IPO
- 1995
- Employees
- 18
- HQ
- Columbia, MD, US
Price Chart
Valuation
- Market Cap
- $15.65K
- P/E
- -0.11
- P/S
- 0.00
- P/B
- -0.01
- EV/EBITDA
- -6.48
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 25.66%
- Op Margin
- -27.03%
- Net Margin
- -3.56%
- ROE
- 5.19%
- ROIC
- -24.91%
Growth & Income
- Revenue
- $3.96M · -48.23%
- Net Income
- $-140,747 · 96.47%
- EPS
- $-0.00 · 99.53%
- Op Income
- $-1,069,869
- FCF YoY
- -156.07%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -23.34
- Avg Volume
- 35.84K
Get TickerSpark's AI analysis on IGNE
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 20, 10 | KIMELMAN MICHAEL | sell | 8,000,000 |
| Jul 16, 09 | KIMELMAN MICHAEL | other | 9,986,904 |
| Jul 16, 09 | KIMELMAN MICHAEL | other | 10,100,066 |
| Jul 16, 09 | KIMELMAN MICHAEL | other | 14,000,000 |
| Jul 16, 09 | KIMELMAN MICHAEL | other | 11,000,000 |
| Dec 3, 08 | KEMPNER THOMAS L | other | 255,139,072 |
| Dec 3, 08 | KEMPNER THOMAS L | other | 11,206,042 |
| Dec 3, 08 | KEMPNER THOMAS L | other | 4,717,706 |
| Dec 3, 08 | KEMPNER THOMAS L | other | 44,429,038 |
| Dec 3, 08 | KEMPNER THOMAS L | other | 22,920,215 |
Our IGNE Coverage
We haven't published any research on IGNE yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IGNE Report →